Ladinin

Ciprofloxacin Hydrochloride, the active ingredient in Ladinin, is a fluoroquinolone antibiotic presented as an oral formulation for systemic use. It treats a range of bacterial infections in adults, including urinary, respiratory, skin and soft‑tissue, and gastrointestinal infections. It is indicated for use in both community and hospital settings, offering a broad spectrum of activity against Gram‑negative and selected Gram‑positive pathogens.

GNH USA supplies Ladinin as a licensed, GDP‑compliant international pharmaceutical product to hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch.

Ladinin (ciprofloxacin hydrochloride) is a fluoroquinolone antibiotic used to treat bacterial infections in various organ systems.

- Urinary tract infection: eradicates susceptible uropathogens, relieving symptoms and preventing complications. - Respiratory tract infection: eliminates common respiratory bacteria, aiding recovery from bronchitis and pneumonia. - Skin and soft tissue infection: clears susceptible skin pathogens, supporting wound healing. - Gastrointestinal infection: targets enteric bacteria, helping resolve dysentery and travel‑related diarrhoea.

Ciprofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea or vomiting: mild gastrointestinal upset. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Dizziness or light‑headedness: occasional vertiginous sensations.

Serious or Rare Side Effects: - Tendon rupture or inflammation: sudden pain in tendons, especially the Achilles. - Central nervous system effects: seizures, confusion, or hallucinations. - Severe allergic reactions: rash, angioedema, or anaphylaxis.

Before prescribing Ladinin, consider the following precautions to ensure safe use. - Renal function: assess kidney function and adjust dose if impairment is present. - Allergy history: avoid in patients with known hypersensitivity to fluoroquinolones or related compounds. - Tendon health: discontinue if tendon pain, swelling, or inflammation occurs. - Central nervous system: monitor patients with a history of seizures or psychiatric disorders. - Pregnancy and lactation: use only when the potential benefit justifies the potential risk to the fetus or infant. - Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Ciprofloxacin can interact with several medicines; awareness of key interactions helps prevent adverse outcomes.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: significantly reduce ciprofloxacin absorption; separate administration by at least 2 hours. - Warfarin: may enhance anticoagulant effect, increasing bleeding risk; monitor INR closely. - Theophylline: ciprofloxacin can increase serum theophylline levels, risking toxicity.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation and seizures. - Diabetic agents (e.g., insulin, sulfonylureas): ciprofloxacin may alter glucose control; monitor blood sugar. - Corticosteroids: concurrent use may raise the chance of tendon disorders.